Navigation Links
Sandia Labs unlocks secrets of plague with stunning new imaging techniques
Date:5/16/2011

ALBUQUERQUE, N.M. Researchers at Sandia National Laboratories have developed a super-resolution microscopy technique that is answering long-held questions about exactly how and why a cell's defenses fail against some invaders, such as plague, while successfully fending off others like E.coli. The approach is revealing never-before-seen detail of the cell membrane, which could open doors to new diagnostic, prevention and treatment techniques.

"We're trying to do molecular biology with a microscope, but in order to do that, we must be able to look at things on a molecular scale," says Jesse Aaron, postdoctoral appointee at Sandia Labs.

The cell membrane is a bustling hub of activity on a miniscule scale. While providing structure and housing the cell's interior, the membrane regulates movement of materials in and out of the cell, controls adhesion to other objects and coordinates the cell's communications and subsequent actions through signaling. Receptor proteins on the surface of immune cells, known as toll-like receptors (TLRs), are tasked with recognizing intruders, or antigens. The TLR4 member of this receptor family responds to certain types of bacteria by detecting lipopolysaccharides (LPS) present on their surface. TLR4 proteins then alert the cell and activate an immune response.

Using imaging techniques they developed, Sandia researchers Aaron, Jeri Timlin and Bryan Carson discovered that TLR4 proteins cluster in the membrane when confronted with LPS derived from E.coli, which increases cell signaling and response. Interestingly, LPS derived from the bacteria that cause plague, Yersinia pestis, do not cause the same effects. This could explain why some pathogens are able to thwart the human immune system.

The plague studies marked the first time such small events have been imaged and compared, the Sandia researchers said. Previously, even the most sophisticated optical microscopes could not image the cell surface with enough spatial resolution to see the earliest binding events, due to the diffraction barrier, which limits what can be resolved using visible light.

"With more traditional visualization methods, you can't see the level of detail you need. It's important to look at not only what's present, but also when and where it's present in the cell," Timlin said.

The technique used by Timlin and Aaron builds on superresolution capabilities developed in recent years, but goes another step by adding dual-color capabilities to the relatively new stochastic optical reconstruction microscopy, or STORM. The combination enables the Sandia team to get a more complete picture by simultaneously imaging LPS and TLR4 receptors on the membrane.

"Current light microscopy capabilities are akin to looking out the window of an airplane and seeing the irrigation circles. You know that plants are there, but you can't tell what kinds of plants they are or what shape the leaves are," said Carson, a Sandia immunologist who was an integral part of the project. "But with this technology, it's like zooming in and seeing the leaves and the structure of the plants. That buys you a lot in terms of understanding what's happening within a cell and specifically how the proteins involved interact."

In 2009, the National Institutes of Health awarded Timlin a five-year, $300,000-a-year innovation grant. Next on the team's agenda is developing the capability to image live cells in real time using spectral Stimulated Emission Depletion, or STED. "We're working toward using a version of superresolution that's much more live-cell friendly, and extending that in terms of what colors are available to do multiple colors, while maintaining the live-cell friendliness. I see this as a beginning of a long development in this type of imaging technology," Timlin said.

Potential applications likely will expand as the technology reveals previously unattainable details of cell signaling. Eventually, the Sandia team would like to be able to visualize protein/protein interactions.

"Every biological process that goes on in your body is somehow controlled by proteins forming complexes with other proteins or complexes in the membrane, so this would give you this ability to look, with high spatial resolution and multiplexed color capabilities, at four or more things in a living cell, which can't be done very easily right now. It can be done in pieces, but we want to see the whole biological process," Timlin said.

The technology has exciting potential in immunology and drug discovery. Improved imaging could show the mechanisms viruses use to invade cells, which might lead to drugs that would block entry. "We're hoping to do something like label the viral particles and watch them in real time, or as close as we can to real time, in the internalization process," Carson said. "With the superresolution technique, we can actually watch them move through the membrane and see if there are other structures being recruited by the virus to the site of internalization."

Sandia originally developed the technology in support of its biological national security programs, but the team wants to expand the technology into other areas such as biofuels to better understand where and when different pigments are located on the membrane of oil-producing algae. This would provide valuable insight into their photosynthesis functions, which could lead to more efficient biofuel production.

"A lot of this work is in its early stages, but we're encouraged by what we're seeing and excited about its future potential," Aaron said.


'/>"/>

Contact: Stephanie Hobby
shobby@sandia.gov
505-844-0948
DOE/Sandia National Laboratories
Source:Eurekalert

Related medicine news :

1. As Science Unlocks Secrets, Cancer Rates Fall
2. Scientist, Dr Staninger, Unlocks the Mystery of Morgellons Disease
3. Genome of marine organism reveals hidden secrets
4. Bilingual neurons may reveal the secrets of brain disease
5. Secrets of plant warfare underpin quest for safer, more secure global food supply
6. Bedbugs Reveal Their Genetic Secrets in Lab Study
7. New tool for cell research may help unravel secrets of disease
8. Scientists decode secrets of a very common virus that can cause cancer
9. Scientists Seek the Secrets of Sour Taste
10. Leading brain scientists meet in Milwaukee to examine how to uncover the brains secrets
11. Scientists Unravel Secrets of Sound Sleep
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/27/2017)... ... 27, 2017 , ... For bicycling enthusiasts around the globe, Germany's famous Rad ... place against a backdrop of tree-lined hills at the Nürburgring, a Formula One arena ... am Ring consists of some 73 curves, stretching out over more than 500 meters ...
(Date:7/27/2017)... ... July 27, 2017 , ... ... secure cloud-based polysomnography (PSG) distributed scoring solution to its healthcare management platform. This ... care management. The speed and functionality of scoring in the cloud is on ...
(Date:7/27/2017)... Plano, TX (PRWEB) , ... July 27, 2017 ... ... technology and outsourced services, announces the internal promotion of Elrene Clinkscales to Vice ... Operations – Claims & Remittance Management, reporting to Derek Morkel, chief executive officer ...
(Date:7/27/2017)... , ... July 27, 2017 , ... ... as a finalist in this year’s Fierce Innovation Awards: Healthcare Edition 2017, an ... finalist in the category of Population Health Management/Patient Engagement Solutions. , MAP ...
(Date:7/27/2017)... ... , ... Cremations recently surpassed traditional burials for the first time in the ... continue with over 70% of Americans projected to choose cremation by 2030. , In ... families to celebrate the life of a lost loved one in different ways using ...
Breaking Medicine News(10 mins):
(Date:7/27/2017)... 27, 2017  West Pharmaceutical Services, Inc. (NYSE: ... the second-quarter 2017 and updated financial guidance for the ... 2017 Highlights Reported net sales of ... prior-year quarter. Net sales at constant currency (organic) grew ... was $0.51, compared to $0.60 in the prior-year quarter. ...
(Date:7/25/2017)... Massachusetts , July 25, 2017 The med-tech ... rare nervous system diseases, has concluded a worldwide license agreement ... drug SOM0226 against transthyretin amyloidosis (ATTR). Before this licensing agreement ... a Phase 2 study conducted in Europe ... the United States ...
(Date:7/21/2017)... SILVER SPRING, Md. and RESEARCH ... -- United Therapeutics Corporation (NASDAQ: UTHR ) ... 2017 financial results before the market opens on Thursday, ... United Therapeutics will host a teleconference on Thursday, July ... is accessible by dialing 1-877-351-5881, with international callers dialing ...
Breaking Medicine Technology: